goiter is situated anteriorly in the mediastinum while posteriorly located goiters were found in 29% of cases. The goiter was on the left side in 57%, on right side in 31% and involving both sides in 12% of cases. Most of the right sided goiters were located posteriorly within the mediastinum. Histopathologically, the goiter was benign in 94% of patients and was resected completely through the cervical approach. The remaining 6% of cases were malignant that required an adjuvant intrathoracic approach. CONCLUSION: Cervical approach is optimum for benign retrosternal goiters reaching level I and level II whether situated anteriorly or posteriorly in the mediastinum. Malignant retrosternal goiters are better approached through intrathoracic approaches.
OBJECTIVE: 1) Describe the outcome of patients who are spared from neck dissection (ND) following concomitant chemoradiation (CRT) based on computed tomography (CT) response. 2) Establish CT characteristics that can predict which patients could safely avoid ND. METHOD: This retrospective study analyzed 369 patients with lymph node positive head and neck cancer treated with primary CRT from January 1998 to December 2007. Following clinical and radiological CT evaluation, patients were classified into complete response (cCR) or partial regional response (cPR). Patients outcomes were estimated using the Kaplan-Meier method and the Log-rank test. Predictive factors for pathologic response and neck recurrence were calculated using univariate analyses. RESULTS: Following CRT, 263 patients reached a cCR including 253 without ND. This was dependent on the N stage (p Ͻ 0.001). Isolated neck recurrence was noted in 4% of patients after cCR. There were no significant differences for 3-year regional control and survival rates between patients with cCR without ND and patients with cPR followed by ND (p Ͼ 0.05). Ninety-six patients reached cPR and underwent ND. Of those, 34 (35%) had residual disease at pathology. CT lymph node focal heterogeneity was well correlated with subsequent pathology results but no association with extracapsular spreading was found. Regression "equal-or-superior-to" 80% of node diameter had a negative predictive value of 100%. CONCLUSION: It is safe to observe node positive patients presenting a cCR determined by CT evaluation 6-8 weeks after CRT. This study also suggests that a lymph node regression 'equal-or-superior-to' 80% on CT following CRT may help guide clinical decisions regarding neck surgery.
Safety of Percutaneous Tracheostomy without Bronchoscopy
Kafeel Ahmed, FRCS (presenter) OBJECTIVE: Percutaneous tracheostomy now seems to be the preferred choice for elective tracheostomy and can be easily done at the bedside in the ICU. In most cases, this is performed under guidance of a bronchoscope. The aim of our study was to determine the safety of percutaneous tracheostomy without the aid of a bronchoscope. METHOD: DESIGN: Between December 2006 and December 2009, 150 critically ill patients on prolonged ventilatory support were prospectively enrolled. SETTING: Intensive care unit of a single tertiary-care referral center. SUBJECTS: One hundred and fifty patients were included (96 male, 54 female) with a mean age of 68 yrs (range, 19-105). INTERVENTION: Bedside percutaneous tracheostomy (using the Ciaglia or the Griggs technique) without the use of bronchoscopy. The technique was modified by using surface markings, blunt dissection and finger palpation of the trachea and a technique to steady the trachea and puncture the trachea with the trocarcannula in approximate midline. MEASUREMENT: We recorded the age and sex of the patients, the airway used by the anesthetist, comorbid conditions, number of days from intubation, procedure time, coagulation study findings, difficulty during procedure, complications, and procedure-related mortality rates. RESULTS: There were 150 patients in our study. The median time from intubation to tracheostomy was 10.6 ϩ/-5.4 days. The vast majority (94%) had their tracheostomy done at bedside in the ICU. In Six patients (4%) the Griggs method was used while the rest (96%) had the Ciaglia single dilatational technique. Mean duration of the procedure was 4.1 ϩ/-2.2 minutes with a range of 2 to 14.5 minutes. Sixteen patients had deranged coagulation profile but these were corrected preoperatively. Overall complication rate was 9.3%. Of the complications 10 were per procedural, and 4 post procedural) and included bleeding (2.7%), desaturation (3.3%), difficult cannulation (1.3%), infection (0.7%), early tube dislodgement (0.7%) and paratracheal tube placement (0.7%). Of the bleeding complications, none were clinically significant and did not require surgical revision. There were no procedure-related deaths. CONCLUSION: A slightly modified technique of percutaneous dilatational tracheostomy without the use of a bronchoscope appears to be a safe and quick technique with a relatively low risk of complications. In experienced hands, this method could be considered as an acceptable alternative.
Sarcomas of the Head and Neck: A Survival Analysis
Seth Lieberman, MD (presenter); Daniel Jethanamest, MD; Luc Morris, MD; Mark DeLacure, MD P201 Poster Presentations POSTERS OBJECTIVE: 1) Describe the behavior of several histologic types of sarcomas of the head and neck using a large cancer registry. 2) Determine prognostic factors for survival using a large cancer registry. METHOD: This is a population-based cohort study using the Surveillance, Epidemiology, and End Results (SEER) database to examine sarcomas of the head and neck from 1973-2005. Overall survival was calculated by histologic type using the Kaplan-Meier method with log-rank comparisons. Pertinent patient data including age, gender, race, histologic grade, histologic type, tumor stage and treatment were evaluated as prognostic factors for overall and disease-specific survival using Cox proportional hazards regression. RESULTS: Of the nine histologies included, malignant fibrous histiocytoma (MFH) was the most common (43.6%), followed by leiomyosarcoma (13.8%), osteosarcoma (9.5%), chondrosarcoma (9.2%), fibrosarcoma (7.5%), rhabdomyosarcoma (6.8%), liposarcoma (6.2%), synovial sarcoma (2.5%), and Ewing sarcoma (1%). The mean age at diagnosis for all types was 61.8, with a male to female ratio of 2.20 to 1. The 5-year overall survival estimates were determined for the various types: MFH (57.5%), leiomyosarcoma (55.2%), osteosarcoma (52.4%), chondrosarcoma (75.5%), fibrosarcoma (58.5%), rhabdomyosarcoma (32.4%), liposarcoma (84.8%), synovial sarcoma (69.5%), and Ewing sarcoma (77.7%). Overall 5-year survival differences between types were statistically significant (pϽ0.001). On multivariate regression, age, stage, histologic type and histologic grade were all independently predictive of overall survival (pϽ0.001). CONCLUSION: Sarcomas of the head and neck exhibit variable overall survival depending on histologic type. Age, stage, grade, histologic type, and treatment are independent predictors of overall survival.
Second Primaries After Major Salivary Gland Cancer
Uchechukwu Megwalu, MD (presenter); Edward Shin, MD OBJECTIVE: 1) Evaluate the risk of second primary cancers in patients with major salivary gland cancer using a large population database. 2) Examine the effects of sex, salivary gland cancer histology, and radiation therapy on the risk of second primaries. METHOD: Data was extracted from the Surveillance, Epidemiology, and End Result (SEER) cancer database. The study cohort consisted of men and women ages 15 and above, diagnosed with major salivary gland cancer from 1973 to 2006. RESULTS: There were 15,572 patients. There was an increased risk of oral cavity, salivary, lung and bronchus, kidney, and thyroid cancers. Men had an increased risk of developing kidney cancer, compared with women. Patients with mucoepidermoid carcinoma had an increased risk of a second salivary gland cancer, and thyroid cancer. Patients with adenoid cystic carcinoma had an increased risk of oral cavity and nasopharyngeal cancers. Patients with acinar cell had an increased risk of salivary, kidney, and thyroid cancers. Patients who received radiation therapy had a higher incidence of lung and bronchus, laryngeal, and thyroid cancers compared with patients who did not receive radiation therapy. Patients had an increased risk of developing second primaries, even 10 years after diagnosis of primary salivary gland cancer. CONCLUSION: Patients with major salivary gland cancers at a risk for certain second primary cancers. This highlights the need for long-term surveillance in these patients, not only for recurrence, but also for second primary cancers.
Sinonasal Undifferentiated Carcinoma: A 24-Year Meta-Analysis
David Reiersen, MD (presenter) OBJECTIVE: Sino-Nasal Undifferentiated Carcinoma (SNUC) is a disease with poor prognosis which has undergone changes in therapeutic options, from non-surgical to combination. Reports in the literature are primarily from smaller series, given the rare nature of this disease. This study attempts to better describe the benefit and survival advantage associated with modern treatment options. METHOD: A PubMed search and review of embedded references was performed using key words to identify reports of sinonasal undifferentiated carcinoma. Individual patient data were extracted for meta-analysis. A database with disease extent/stage, treatment modalities, survival, disease status, and follow-up was created. The information in this database was used to create cohorts for data analysis including Kaplan-Meier curves. RESULTS: Between January 1986 to October 2009, 28 papers with 152 patients were identified. Follow-up ranged from one to 195 months (mean 23.2 months, median 14 months). At last follow-up, 25.0% of the patients were alive with no evidence of disease, 22.4% were alive with disease, and 52.6% were dead of disease. The comparison of similarly staged diseases by treatment modalities (surgery, radiation, chemotherapy, or combination) were significantly different (pϭ0.0270 with Kadish staging, pϭ0.0032 using AJCC, pϽ0.0001 using reported anatomical extent). The best patient survival was associated with the use of surgery, radiation, and chemotherapy in combination. CONCLUSION: In review of the pooled cohort of data, the survival from SNUC is poor, but the data analysis reinforces that optimal treatment consists of surgery, radiation, and chemotherapy.
Spinal Hardware Induced Cervical Esophageal Perforations
Christopher Surek, BS (presenter); Douglas Girod, MD
